Commvault executives sold $9.4 million in stock after 31% crash

Commvault Systems executives sold $9.4 million in stock after the company's shares plunged 31% on disappointing quarterly results.

"We're investigating whether Commvault misled investors regarding its ARR growth by masking the impact of lower-priced SaaS deals and heavy discounting," Reed Kathrein, partner at Hagens Berman, said.

The insider sales occurred between February and May 2026, after the Jan. 27 stock collapse erased $1.7 billion in market value. Chief Executive Officer Sanjay Mirchandani sold about 72,874 shares worth more than $7 million across five transactions. Chief Financial Officer Gary Merrill sold about 20,474 shares totaling $2.1 million, and Chief Accounting Officer Danielle Nicole Abrahamsen sold about 2,951 shares worth $305,668, according to publicly filed insider trading reports.

The sales come as Commvault faces a federal securities class action alleging it misled investors about its growth trajectory during the class period from April 29, 2025, to Jan. 26, 2026. Investors have until July 17, 2026, to apply for lead plaintiff status.

The lawsuit claims Commvault repeatedly touted that its "execution has never been better across the business" and that it would "continue to see hyper-growth within its SaaS platform," while failing to disclose that its annualized recurring revenue growth was being diluted by lower-priced SaaS deals and heavy discounting.

The truth emerged on Jan. 27, when Commvault reported third-quarter fiscal 2026 net new ARR of $39 million, missing its $45 million target. SaaS ARR year-over-year growth decelerated to 40% from 71%. Several analysts downgraded the stock, with CFRA cutting its price target to $101 from $172 and Mizuho lowering its target to $140 from $180.

DA Davidson analysts said management's explanations for the miss "leave many with questions" and did "not seem to have been enough for investors."

The 31% single-day decline pushed Commvault shares to $89.13 from $129.36. The stock has partially recovered, trading at $130.76 as of June 24.

The decline puts the stock near its pre-crash recovery level, testing whether the company can rebuild investor confidence. The next catalyst is the lead plaintiff deadline on July 17, which will determine how the litigation proceeds.

This article is for informational purposes only and does not constitute investment advice.